Stocks and Investing
Stocks and Investing
Tue, November 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gena Wang Maintained (ARCT) at Sell with Decreased Target to $31 on, Nov 9th, 2021
Gena Wang of Barclays, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Sell with Decreased Target from $46 to $31 on, Nov 9th, 2021.
Gena has made no other calls on ARCT in the last 4 months.
There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 0 agree with Gena's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Gena
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $114 on, Wednesday, August 25th, 2021
- Steven Seedhouse of "Raymond James" Downgraded from Hold to Sell on, Thursday, August 12th, 2021
- Madhu Kumar of "Goldman Sachs" Downgraded from Hold to Strong Sell and Held Target at $29 on, Wednesday, August 11th, 2021
- Brian Cheng of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $85 on, Tuesday, August 10th, 2021
- Joel Beatty of "Baird" Downgraded from Hold to Sell on, Tuesday, August 10th, 2021
Contributing Sources